Goal of surgery for patients with Glioblastoma Multiforme (GBM) is gross total resection with no new neurological deficits. Surgical resection is often restricted due the difficulty in differentiating the tumour from surrounding normal brain using either naked eye, or standard intra-operative white light microscopy. GBM uptakes orally administered 5-ALA becomes fluorescent when viewed by a special light, and this property has been used to improve intra-operative tumour identification. This technique should therefore allow better extent of tumour resection. The hypothesis has been tested through several studies and even though most studies are of low quality, they strongly favour the use of 5- ALA in improving the extent of resection when co...
BACKGROUND: During the last decade, the use of 5-aminolevulinic acid (5-ALA) has been steadily incre...
Summary: Background: 5-Aminolevulinic Acid (5-ALA) induced fluorescence is useful in guiding glioma...
Objective: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan®) in patients treated fo...
Introduction5-aminolevulinic acid (5-ALA) is a proagent developed for fluorescent-guided surgery for...
Background: The technique of 5-aminolevulinic acid (5-ALA) tumor fluorescence is increasingly used t...
BACKGROUND: Glioma surgery at its nascency relied predominantly on visual and tactile feedback for t...
cited By 0International audienceBackground: When feasible, the surgical resection is the standard fi...
There is rising evidence that in glioblastoma(GBM) surgery an increase of extent of resection(EoR) l...
Altres ajuts: TRA-085Altres ajuts: EC11-040Background: During the last decade, the use of 5-aminolev...
Introduction. – High-grade gliomas surgery in eloquent areas must achieve two pivotal aims: oncologi...
Background: Glioblastoma multiforme (GBM) is one of the most deadly cancers in humans. Despite recen...
BACKGROUND: Glioblastoma resection guided by 5-aminolevulinic acid (5-ALA) fluorescence and intraope...
Background There is rising evidence that in glioblastoma(GBM) surgery an increase of extent of resec...
High-grade glioma (HGG) is associated with a dismal prognosis despite significant advances in adjuva...
High-grade gliomas (HGGs) are the most frequent primary malignant brain tumors in adults, which lead...
BACKGROUND: During the last decade, the use of 5-aminolevulinic acid (5-ALA) has been steadily incre...
Summary: Background: 5-Aminolevulinic Acid (5-ALA) induced fluorescence is useful in guiding glioma...
Objective: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan®) in patients treated fo...
Introduction5-aminolevulinic acid (5-ALA) is a proagent developed for fluorescent-guided surgery for...
Background: The technique of 5-aminolevulinic acid (5-ALA) tumor fluorescence is increasingly used t...
BACKGROUND: Glioma surgery at its nascency relied predominantly on visual and tactile feedback for t...
cited By 0International audienceBackground: When feasible, the surgical resection is the standard fi...
There is rising evidence that in glioblastoma(GBM) surgery an increase of extent of resection(EoR) l...
Altres ajuts: TRA-085Altres ajuts: EC11-040Background: During the last decade, the use of 5-aminolev...
Introduction. – High-grade gliomas surgery in eloquent areas must achieve two pivotal aims: oncologi...
Background: Glioblastoma multiforme (GBM) is one of the most deadly cancers in humans. Despite recen...
BACKGROUND: Glioblastoma resection guided by 5-aminolevulinic acid (5-ALA) fluorescence and intraope...
Background There is rising evidence that in glioblastoma(GBM) surgery an increase of extent of resec...
High-grade glioma (HGG) is associated with a dismal prognosis despite significant advances in adjuva...
High-grade gliomas (HGGs) are the most frequent primary malignant brain tumors in adults, which lead...
BACKGROUND: During the last decade, the use of 5-aminolevulinic acid (5-ALA) has been steadily incre...
Summary: Background: 5-Aminolevulinic Acid (5-ALA) induced fluorescence is useful in guiding glioma...
Objective: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan®) in patients treated fo...